Wolfsburg, Germany

Galina Sergeev

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helmholtz-Zentrum Fuer Infektionsforschung Gmbh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Galina Sergeev. Retrieved from https://idiyas.com/inventor/galina-sergeev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Galina Sergeev: Innovator in Bacterial Targeting Agents

Introduction

Galina Sergeev is a notable inventor based in Wolfsburg, Germany. She has made significant contributions to the field of pharmaceutical compositions, particularly in the development of agents that target bacteria. Her innovative work has the potential to enhance diagnostic and therapeutic methods in medicine.

Latest Patents

Galina Sergeev holds 1 patent for her invention titled "1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use." This invention relates to new compounds that include a siderophore moiety and a core structure capable of chelating metal ions. The compounds may also feature a functional element such as a marker molecule or a bioactive agent, which can be used to monitor protein activity related to bacterial infections. Furthermore, her invention encompasses a pharmaceutical composition that can serve as an antibiotic and is applicable in various diagnostic methods, including imaging techniques like SPEC, PET, or MRI.

Career Highlights

Throughout her career, Galina has worked with prestigious institutions, including the Helmholtz-Zentrum für Infektionsforschung GmbH. Her research has focused on innovative solutions to combat bacterial infections, showcasing her commitment to advancing medical science.

Collaborations

Galina has collaborated with esteemed colleagues such as Mark Broenstrup and Haiyu Hu. These partnerships have contributed to her research and the development of her patented inventions.

Conclusion

Galina Sergeev's work in developing targeted bacterial agents represents a significant advancement in the field of pharmaceuticals. Her innovative approach has the potential to improve both diagnostic and therapeutic strategies in combating bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…